Current issues in human subject protection : an FDA perspective : September 13, 1996, Natcher Auditorium

LDR			01172nam a2200349 a 4500
001			003135854
003			MiAaHDL
005			20111213000000.0
006			m d
007			cr bn ---auaua
008			961018s1996 mdua b f000 0 eng d
035	⊔	⊔	‡asdr-umn001197458
035	⊔	⊔	‡a(OCoLC)35757801
035	⊔	⊔	‡a(GPO)96082343
035	⊔	⊔	‡a(GPO)96082343
035	⊔	⊔	‡a(MvI)96274042
035	⊔	⊔	‡a(MnU)notisAQZ0672
040	⊔	⊔	‡aGPO ‡cGPO ‡dDLC ‡dMvI
043	⊔	⊔	‡an-us---
049	⊔	⊔	‡aMNDA
049	⊔	⊔	‡aMNUA
074	⊔	⊔	‡a0475
086	0	⊔	‡aHE 20.4002:H 88
086	0	⊔	‡aHE 20.4002:H 88
099	⊔	⊔	‡aHE 20.4002:H 88
245	0	0	‡aCurrent issues in human subject protection : ‡ban FDA perspective : September 13, 1996, Natcher Auditorium.
260	⊔	⊔	‡a[Rockville, MD] : ‡bFood and Drug Administration, ‡c[1996?]
300	⊔	⊔	‡a1 v. (various pagings) : ‡bill. ; ‡c28 cm.
500	⊔	⊔	‡aShipping list no.: 96-0328-P.
504	⊔	⊔	‡aIncludes bibliographical references.
538	⊔	⊔	‡aMode of access: Internet.
650	⊔	0	‡aClinical trials ‡xGovernment policy ‡zUnited States.
650	⊔	0	‡aHuman experimentation in medicine ‡xGovernment policy ‡zUnited States.
710	1	⊔	‡aUnited States. ‡bFood and Drug Administration
CID	⊔	⊔	‡a003135854
DAT	0	⊔	‡a20100105095025.0 ‡b20111213000000.0
DAT	1	⊔	‡a20120815122756.0 ‡b2024-02-20T19:11:13Z
CAT	⊔	⊔	‡aSDR-UMN ‡dUNKNOWN ‡lloader.pl-001-001
FMT	⊔	⊔	‡aBK
HOL	⊔	⊔	‡0sdr-umn001197458 ‡aumn ‡bSDR ‡cUMN ‡pumn.31951d02465636d ‡sUMN ‡1001197458
974	⊔	⊔	‡bUMN ‡cUMN ‡d20240220 ‡sgoogle ‡uumn.31951d02465636d ‡y1996 ‡rpd ‡qbib ‡tUS fed doc